Heart Failure

Heart Failure - 2017 Update

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/244042

Contents of this Issue

Navigation

Page 9 of 61

10 Prevention ACC/AHA Stage A/B HF BNP or NT-proBNP (COR IIa) Diagnosis Colors correspond to COR/LOE Table. For all medical therapies, dosing should be optimized and serial assessment exercised. * Other biomarkers of injury or fibrosis include soluble ST2 receptor, galectin-3, and high-sensitivity troponin. Diagnosis Prognosis or added risk stratification At risk for HF Figure 1. Biomarkers Indications for Use (2017)

Articles in this issue

view archives of Heart Failure - Heart Failure - 2017 Update